TDAC stock news
This page provides real-time market news, earnings updates, and company announcements related to Translational Development Acquisition Corp. (TDAC).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-09 06:54 EST
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-27 10:03:48
Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Finviz2026-03-27 12:03:49
Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn's Disease
Finviz2026-03-30 20:06:12
Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results
Finviz2026-03-30 20:06:12
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
Finviz2026-03-31 12:03:48
Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) in Advanced and Metastatic Triple-Negative Breast Cancer
Finviz2026-03-31 12:06:48
Visionary Holdings Signs Cooperation Agreement with Strategic Investment Partner for Proposed US$20 Million Investment in Qingdao Anti-Aging Project
Finviz2026-03-31 14:06:41
Imunon Inc’s 2025 Q4 Earnings Call: FDA Submission Delays, Shifting Trial Timelines, and Enrollment Discrepancies Highlight Contradictions
101 finance2026-03-31 17:16:06
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Finviz2026-03-31 20:03:46
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
Finviz2026-04-01 10:48:48
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
Finviz2026-04-01 11:25:07
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
Finviz2026-04-01 12:03:45
Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
Finviz2026-04-01 20:06:55
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
Finviz2026-04-02 11:03:12
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
Finviz2026-04-02 11:33:09
Seaport’s initial success confirms the effectiveness of the Glyph platform and establishes a strong foundation for a pivotal Phase 2 milestone.
101 finance2026-04-02 11:39:41
Picard Medical / SynCardia COO to Deliver Keynote at Venture Cafe Phoenix During Arizona Tech Week
Finviz2026-04-02 12:03:41
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma
Finviz2026-04-02 12:03:43
BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology
Finviz2026-04-02 13:03:07
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-02 20:09:53
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-06 11:03:55
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting
Finviz2026-04-06 11:34:00
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion
Finviz2026-04-07 13:09:49
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
Finviz2026-04-08 12:03:53
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
Finviz2026-03-31 12:03:48
Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) in Advanced and Metastatic Triple-Negative Breast Cancer
Finviz2026-03-31 12:06:48
Visionary Holdings Signs Cooperation Agreement with Strategic Investment Partner for Proposed US$20 Million Investment in Qingdao Anti-Aging Project
Finviz2026-03-31 14:06:41
Imunon Inc’s 2025 Q4 Earnings Call: FDA Submission Delays, Shifting Trial Timelines, and Enrollment Discrepancies Highlight Contradictions
101 finance2026-03-31 17:16:06
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Finviz2026-03-31 20:03:46
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
Finviz2026-04-01 10:48:48
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
Finviz2026-04-01 11:25:07
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
Finviz2026-04-01 12:03:45
Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
Finviz2026-04-01 20:06:55
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
Finviz2026-04-02 11:03:12
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
Finviz2026-04-02 11:33:09
Seaport’s initial success confirms the effectiveness of the Glyph platform and establishes a strong foundation for a pivotal Phase 2 milestone.
101 finance2026-04-02 11:39:41
Picard Medical / SynCardia COO to Deliver Keynote at Venture Cafe Phoenix During Arizona Tech Week
Finviz2026-04-02 12:03:41
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma
Finviz2026-04-02 12:03:43
BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology
Finviz2026-04-02 13:03:07
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-02 20:09:53
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-06 11:03:55
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting
Finviz2026-04-06 11:34:00
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion
Finviz2026-04-07 13:09:49
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
Finviz2026-04-08 12:03:53
TDAC stock chart
TDAC stock detailsTDAC stock price change
On the last trading day, TDAC stock closed at 10.58 USD, with a price change of -0.19% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more